Cypress Capital’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$802K Sell
14,741
-982
-6% -$47.8K 0.22% 61
2026
Q1
$674K Sell
15,723
-913
-5% -$39.3K 0.19% 60
2025
Q4
$729K Sell
16,636
-1,218
-7% -$50.4K 0.2% 57
2025
Q3
$737K Buy
+17,854
New +$718K 0.21% 56

Other funds holding EXEL

Cypress Capital's EXEL Position: Q2 2026 in Review

Cypress Capital reduced its Exelixis (EXEL) stake by 6.2% in Q2 2026, selling an estimated $47.8K and leaving 14,741 shares worth $802K. The position accounts for 0.22% of the portfolio, ranked #61.

Cypress Capital first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Cypress Capital held 14,741 shares of Exelixis worth $802K as of Q2 2026.
  • Cypress Capital sold 982 Exelixis shares in Q2 2026, an estimated $47.8K.
  • Exelixis made up 0.22% of Cypress Capital's portfolio in Q2 2026, its #61 holding.
  • Cypress Capital first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.